Skip to main content

MoneyWorks4Me

Nutraplus India informs about quarterly statement on investor complaints

12 Apr 2016 Evaluate

Nutraplus India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.75
Dr. Reddys Labs. 1312.60
Cipla 1344.65
Lupin 1950.50
Zydus Lifesciences 1169.00
View more..